Trial Profile
A Double Blind, Randomized, Placebo-controlled, Parallel Group, Multi-center, Phase III Study to Assess the Efficacy and Safety of SK3530 in Patients With Erectile Dysfunction Taking Antihypertensive Medication
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Jan 2019
Price :
$35
*
At a glance
- Drugs Mirodenafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- 17 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.